Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFocus remains on R&D to drive growth of blockbuster drugs, says Novartis CEOVas Narasimhan, CEO at Novartis, discusses third-quarter results, and explains the strategy behind development of the company's most in-demand treatments.
Persons:
Vas
Organizations:
Novartis